Frontiers in nephrology: Early atherosclerosis - A view beyond the lumen

Journal of the American Society of Nephrology

Volumn 18, Issue 11, 2007, Pages 2836-2842

  Gossl, Mario ^a   Lerman, Lilach O ^a   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; HUMAN; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); NEPHROLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL MOBILIZATION; VASA VASORUM;

EID: 35848965917     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2007030333     Document Type: Review

References (49)

1. Ross R: Atherosclerosis: An inflammatory disease. N Engl J Med 340: 115-126, 1999
2. Bobryshev YV, Lord RS: Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovasc Res 37: 799-810, 1998
3. Wilcox JN, Scott NA: Potential role of the adventitia in arteritis and atherosclerosis. Int J Cardiol 54[Suppl]: S21-S35, 1996
4. Okamoto E, Couse T, De Leon H, Vinten-Johansen J, Goodman RB, Scott NA, Wilcox JN: Perivascular inflammation after balloon angioplasty of porcine coronary arteries. Circulation 104: 2228-2235, 2001
5. Moos MP, John N, Grabner R, Nossmann S, Gunther B, Vollandt R, Funk CD, Kaiser B, Habenicht AJ: The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 25: 2386-2391, 2005
6. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A: Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101: 948-954, 2000
7. Lerman A, Zeiher AM: Endothelial function: Cardiac events. Circulation 111: 363-368, 2005
8. Bonetti PO, Lerman LO, Lerman A: Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23: 168-175, 2003
9. Eriksson A, Cao R, Roy J, Tritsaris K, Wahlestedt C, Dissing S, Thyberg J, Cao Y: Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability. Circulation 107: 1532-1538, 2003
10. Gossl M, Rosol M, Malyar NM, Fitzpatrick LA, Beighley PE, Zamir M, Ritman EL: Functional anatomy and hemodynamic characteristics of vasa vasorum in the walls of porcine coronary arteries. Anat Rec A Discov Mol Cell Evol Biol 272: 526-537, 2003
11. Gossl M, Versari D, Mannheim D, Ritman EL, Lerman LO, Lerman A: Increased spatial vasa vasorum density in the proximal LAD in hypercholesterolemia: Implications for vulnerable plaque-development. Atherosclerosis 192: 246-252, 2007
12. de Boer OJ, van der Wal AC, Teeling P, Becker AE: Leucocyte recruitment in rupture prone regions of lipid-rich plaques: A prominent role for neovascularization? Cardiovasc Res 41: 443-449, 1999
13. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, Lo KM, Gillies S, Javaherian K, Folkman J: Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A 100: 4736-4741, 2003
14. Gossl M, Beighley PE, Malyar NM, Ritman EL: Transendothelial solute transport in the coronary vessel wall: Role of vasa vasorum - A study with cryostatic micro-CT. Am J Physiol Heart Circ Physiol 287: H2346-H2351, 2004
15. Herrmann J, Lerman LO, Rodriguez-Porcel M, Holmes DR, Richardson DM, Ritman EL, Lerman A: Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc Res 51: 762-766, 2001
16. Herrmann J, Samee S, Chade A, Porcel MR, Lerman LO, Lerman A: Differential effect of experimental hypertension and hypercholesterolemia on adventitial remodeling. Arterioscler Thromb Vasc Biol 25: 447-453, 2005
17. Kwon HM, Sangiorgi G, Ritman EL, McKenna C, Holmes DR Jr, Schwartz RS, Lerman A: Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest 101: 1551-1556, 1998
18. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, Narula J, Finn AV, Virmani R: Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349: 2316-2325, 2003
19. Moulton KS: Plaque angiogenesis and atherosclerosis. Curr Atheroscler Rep 3: 225-233, 2001
20. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, Wrenn SP, Narula J: Atherosclerotic plaque progression and vulnerability to rupture: Angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25: 2054-2061, 2005
21. Galili O, Herrmann J, Woodrum J, Sattler KJ, Lerman LO, Lerman A: Adventitial vasa vasorum heterogeneity among different vascular beds. J Vasc Surg 40: 529-535, 2004
22. Galili O, Sattler KJ, Herrmann J, Woodrum J, Olson M, Lerman LO, Lerman A: Experimental hypercholesterolemia differentially affects adventitial vasa vasorum and vessel structure of the left internal thoracic and coronary arteries. J Thorac Cardiovasc Surg 129: 767-772, 2005
23. Langheinrich AC, Michniewicz A, Sedding DG, Walker G, Beighley PE, Rau WS, Bohle RM, Ritman EL: Correlation of vasa vasorum neovascularization and plaque progression in aortas of apolipoprotein E(-/-)/low-density lipoprotein(-/-) double knockout mice. Arterioscler Thromb Vasc Biol 26: 347-352, 2006
24. Depre C, Havaux X, Wijns W: Neovascularization in human coronary atherosclerotic lesions. Cathet Cardiovasc Diagn 39: 215-220, 1996
25. Depre C, Wijns W, Robert AM, Renkin JP, Havaux X: Pathology of unstable plaque: Correlation with the clinical severity of acute coronary syndromes. J Am Coll Cardiol 30: 694-702, 1997
26. MacNeill BD, Jang I-K, Bouma BE, Iftimia N, Takano M, Yabushita H, Shishkov M, Kauffman CR, Houser SL, Aretz HT: Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol 44: 972-979, 2004
27. Moulton KS, Heller E, Konerding MA, Flynn E, Palinski W, Folkman J: Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99: 1726-1732, 1999
28. Wassmann S, Werner N, Czech T, Nickenig G: Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ Res 99: e74-e83, 2006
29. Murphy C, Kanaganayagam GS, Jiang B, Chowienczyk PJ, Zbinden R, Saha M, Rahman S, Wheatcroft S, Shah AM, Marber MS, Kearney MT: Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. Arterioscler Thromb Vasc Biol 27: 936-942, 2007
30. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600, 2003
31. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G: Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999-1007, 2005
32. Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, Dimmeler S, Zeiher AM: Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair. Circulation 111: 2981-2987, 2005
33. Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R, De Ferrari GM, Ferlini M, Goffredo L, Bertoletti A, Klersy C, Pecci A, Moratti R, Tavazzi L: Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105: 199-206, 2005
34. Wojakowski W, Tendera M, Michalowska A, Majka M, Kucia M, Maslankiewicz K, Wyderka R, Ochala A, Ratajczak MZ: Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 110: 3213-3220, 2004
35. Guven H, Shepherd RM, Bach RG, Capoccia BJ, Link DC: The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol 48: 1579-1587, 2006
36. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA: Re-defining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109: 1801-1809, 2007
37. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC: Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106: 2781-2786, 2002
38. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, Dimmeler S: Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9: 1370-1376, 2003
39. Gabbasov ZA, Agapov AA, Saburova OS, Obedzinskii EA, Soboleva EL: Detection of circulating stromal stem cells with osteogenic potential in the blood of coronary patients by laser flow cytometry. Bull Exp Biol Med 139: 266-268, 2005
40. Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W, Sung J, Jeon ES, Oh HY, Kim DK: Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 24: 1246-1252, 2004
41. Torsney E, Mandal K, Halliday A, Jahangiri M, Xu Q: Characterisation of progenitor cells in human atherosclerotic vessels. Atherosclerosis 191: 259-264, 2007
42. George J, Afek A, Abashidze A, Shmilovich H, Deutsch V, Kopolovich J, Miller H, Keren G: Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 25: 2636-2641, 2005
43. Lu X, Dunn J, Dickinson AM, Gillespie JI, Baudouin SV: Smooth muscle alpha-actin expression in endothelial cells derived from CD34+ human cord blood cells. Stem Cells Dev 13: 521-527, 2004
44. Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, Nickenig G: Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93: e17-e24, 2003
45. Khurana R, Simons M, Martin JF, Zachary IC: Role of angiogenesis in cardiovascular disease: A critical appraisal. Circulation 112: 1813-1824, 2005
46. Eggebrecht H, Rodermann J, Hunold P, Schmermund A, Bose D, Haude M, Erbel R: Images in cardiovascular medicine: Novel magnetic resonance-compatible coronary stent - The absorbable magnesium-alloy stent. Circulation 112: e303-e304, 2005
47. Napoli C, Lerman LO, de Nigris F, Gossl M, Balestrieri ML, Lerman A: Rethinking primary prevention of atherosclerosis-related diseases. Circulation 114: 2517-2527, 2006
48. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, Dimmeler S: Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103: 2885-2890, 2001
49. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rutten H, Fichtlscherer S, Martin H, Zeiher AM: HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108: 391-397, 2001